Need help finding what you are looking for?
Contact Us
PUBLISHER: Visiongain | PRODUCT CODE: 1697636
PUBLISHER: Visiongain | PRODUCT CODE: 1697636
Pharmaceutical Contract Manufacturing Market Report 2025-2035
PUBLISHED:
PAGES: 355 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global Pharmaceutical Contract Manufacturing market is projected to grow at a CAGR of 11.8% by 2035.
The Pharmaceutical Contract Manufacturing Market Report 2025-2035: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to understand the industry and its underlying dynamics better. It will also be helpful for companies that would like to expand into different sectors or expand their existing operations in a new region.
Expanding Role of CMOs in Drug Development & Commercialisation
The pharmaceutical contract manufacturing sector is no longer confined to large-scale drug production; it now plays an integral role in the entire drug development lifecycle, from clinical trial production to commercialisation. Leading CMOs provide comprehensive services, including:
Formulation Development: Expertise in optimising drug formulations for stability, bioavailability, and patient compliance.
Clinical Manufacturing: Production of investigational drugs for clinical trials, ensuring GMP-compliant processes.
Regulatory Support: Assisting pharmaceutical firms in navigating complex global regulatory requirements.
Supply Chain Management: Ensuring seamless raw material sourcing, production, and distribution to meet global demand.
As the demand for complex biologics, cell and gene therapies, and high-potency active pharmaceutical ingredients (HPAPIs) rises, CMOs are expanding their capabilities to meet evolving industry needs. Their role in facilitating faster drug approvals and global market access is becoming increasingly vital.
The Evolution of Pharmaceutical Contract Manufacturing: A Strategic Imperative for Industry Growth
The global pharmaceutical sector is undergoing rapid transformation, driven by the urgent need to efficiently bring innovative drugs to market. This shift has reinforced the strategic importance of Contract Manufacturing Organisations (CMOs), which play a crucial role in streamlining production processes while reducing pharmaceutical companies' operational and capital expenditures. With escalating drug development costs, increasing demand for both branded and generic medicines, and the integration of cutting-edge technologies, the pharmaceutical contract manufacturing market is poised for significant expansion.
What Questions Should You Ask Before Buying a Market Research Report?
- How is the pharmaceutical contract manufacturing market evolving?
- What is driving and restraining the pharmaceutical contract manufacturing market?
- How will each pharmaceutical contract manufacturing submarket segment grow over the forecast period, and how much revenue will these submarkets account for in 2035?
- How will the market shares for each pharmaceutical contract manufacturing submarket develop from 2025 to 2035?
- What will be the main driver for the overall market from 2025 to 2035?
- Will leading pharmaceutical contract manufacturing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2035, and which geographical region will lead the market in 2035?
- Who are the leading players, and what are their prospects over the forecast period?
- What are the pharmaceutical contract manufacturing projects for these leading companies?
- How will the industry evolve during the period between 2025 and 2035? What are the implications of pharmaceutical contract manufacturing projects now and over the next 10 years?
- Is there a greater need for product commercialisation to further scale the pharmaceutical contract manufacturing market?
- Where is the pharmaceutical contract manufacturing market heading, and how can you ensure you are at the forefront?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the pharmaceutical contract manufacturing market today and over the next 10 years:
- Our 355-page report provides you with 147 tables and 201 charts/graphs exclusively.
- The report highlights key lucrative areas in the industry so you can target them NOW.
- It contains in-depth analysis of global, regional and national sales and growth.
- It highlights the key successful trends, changes and revenue projections made by your competitors.
- Forecasts to 2035 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2035, our new study provides recent results, growth rates, and market shares.
- You will find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.
Segments Covered in the Report
- Services
- Pharmaceutical Manufacturing Services
- Drug Development Services
- Biologics Manufacturing Services
- Drug Type
- Branded
- Generics
- End-users
- Big Pharmaceutical Companies
- Small & Medium-sized Pharmaceutical Companies
- Generic Pharmaceutical Companies
- Other End-users
- Scale of Operation
- Clinical
- Commercial
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 27 leading national markets:
- North America
- U.S.
- Canada
- Europe
- GerU.Sy
- UK
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- MEA
- GCC
- South Africa
- Rest of MEA
The report also includes profiles of some of the leading companies in the Pharmaceutical Contract Manufacturing Market from 2025 to 2035, focusing on this segment of their operations.
- Leading companies and the potential for market growth
- AbbVie Inc.
- Abnova Corporation
- Aenova Group
- Almac Group
- Baxter
- Boehringer Ingelheim International GmbH
- Catalent, Inc.
- Charles River Laboratories
- Curia Global, Inc.
- Evonik Industries AG
- FUJIFILM Diosynth Biotechnologies
- Grifols, S.A.
- ICON plc
- IQVIA Inc.
- Jubilant Pharmova Limited
- Lannett
- Lonza
- Nipro Pharma Corporation
- Piramal Pharma Solutions
- Pfizer Inc.
- Recipharm AB
- Samsung Biologics
- Siegfried Holding AG
- Thermo Fisher Scientific Inc.
- Vetter Pharma
- WuXi AppTec
Overall world revenue for Pharmaceutical Contract Manufacturing Market, 2025 to 2035 in terms of value the market will surpass US$170 billion in 2025, our work calculates. We predict strong revenue growth through to 2035. Our work identifies which organisations hold the most significant potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
- How will the Pharmaceutical Contract Manufacturing Market 2025 to 2035 report help you?
- In summary, our 350+ page report provides you with the following knowledge:
- Revenue forecasts to 2035 for Pharmaceutical Contract Manufacturing Market 2025 to 2035, with forecasts for services, drug type, end-users, and scale of operation, each estimated at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2035 for five regional and 27 key national markets - See forecasts for the Pharmaceutical Contract Manufacturing Market, 2025 to 2035 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia, among other prominent economies.
- Prospects for established firms and those seeking to enter the market - including company profiles for 26 of the major companies involved in the Pharmaceutical Contract Manufacturing Market, 2025 to 2035.
- Find quantitative and qualitative analysis with independent predictions and invaluable business intelligence.
Product Code: PHA1368
Table of Contents
1 Report Overview
- 1.1 Objectives of the Study
- 1.2 Introduction to Pharmaceutical Contract Manufacturing Market
- 1.3 What This Report Delivers
- 1.4 Why You Should Read This Report
- 1.5 Key Questions Answered by This Analytical Report Include:
- 1.6 Who is This Report For?
- 1.7 Methodology
- 1.7.1 Market Definitions
- 1.7.2 Market Evaluation & Forecasting Methodology
- 1.7.3 Data Validation
- 1.7.3.1 Primary Research
- 1.7.3.2 Secondary Research
- 1.8 Frequently Asked Questions (FAQs)
- 1.9 Associated Visiongain Reports
- 1.10 About Visiongain
2 Executive Summary
3 Market Overview
- 3.1 Key Findings
- 3.2 Market Dynamics
- 3.3 Impact Analysis
- 3.3.1 Market Driving Factors
- 3.3.1.1 Patent Expiry and Increasing Demand for Generic Drugs
- 3.3.1.2 Increasing Investments in Pharmaceutical R&D
- 3.3.1.3 Investments in Advanced Manufacturing Technologies by CDMOs
- 3.3.2 Market Restraining Factors
- 3.3.2.1 Introduction of Serialization
- 3.3.2.2 Varying Regulatory Scenarios
- 3.3.3 Market Opportunities
- 3.3.3.1 Increasing Demand for Biological Therapies
- 3.3.3.2 Growth in the Nuclear Medicine Sector
- 3.3.3.3 Growing Demand for Cell and Gene Therapies
- 3.3.3.4 Growth Opportunities in Emerging Countries
- 3.3.1 Market Driving Factors
- 3.4 Regulatory Framework
- 3.5 Emerging Markets and Megatrends
- 3.6 Porter's Five Forces Analysis
- 3.6.1 Bargaining Power of Supplier
- 3.6.2 Bargaining Power of Buyer
- 3.6.3 Threat of New Entrants
- 3.6.4 Threat of Substitutes
- 3.6.5 Competitive Rivalry
- 3.7 PEST Analysis
- 3.8 SWOT Analysis
- 3.9 Key Trends Impacting the Industry
- 3.9.1 Transition to Continuous Manufacturing
- 3.9.2 Adoption of Single-use Systems in Biologics
- 3.9.3 Integration of Digital Technologies
- 3.9.4 Emphasis on Sustainability and Green Manufacturing
- 3.9.5 Navigating Regulatory Challenges
4 Pharmaceutical Contract Manufacturing Market Analysis by Services
- 4.1 Key Findings
- 4.2 Services Segment: Market Attractiveness Index
- 4.3 Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Services
- 4.4 Pharmaceutical Manufacturing Services
- 4.4.1 Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
- 4.4.2 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- 4.4.3 Market Share by Region, 2025 & 2035 (%)
- 4.5 Drug Development Services
- 4.5.1 Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
- 4.5.2 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- 4.5.3 Market Share by Region, 2025 & 2035 (%)
- 4.6 Biologics Manufacturing Services
- 4.6.1 Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
- 4.6.2 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- 4.6.3 Market Share by Region, 2025 & 2035 (%)
5 Pharmaceutical Contract Manufacturing Market Analysis by Drug Type
- 5.1 Key Findings
- 5.2 Drug Type Segment: Market Attractiveness Index
- 5.3 Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Drug Type
- 5.4 Branded
- 5.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- 5.4.2 Market Share by Region, 2025 & 2035 (%)
- 5.5 Generics
- 5.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- 5.5.2 Market Share by Region, 2025 & 2035 (%)
6 Pharmaceutical Contract Manufacturing Market Analysis by End-users
- 6.1 Key Findings
- 6.2 End-users Segment: Market Attractiveness Index
- 6.3 Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by End-users
- 6.4 Big Pharmaceutical Companies
- 6.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- 6.4.2 Market Share by Region, 2025 & 2035 (%)
- 6.5 Small & Medium-sized Pharmaceutical Companies
- 6.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- 6.5.2 Market Share by Region, 2025 & 2035 (%)
- 6.6 Generic Pharmaceutical Companies
- 6.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- 6.6.2 Market Share by Region, 2025 & 2035 (%)
- 6.7 Other End-users
- 6.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- 6.7.2 Market Share by Region, 2025 & 2035 (%)
7 Pharmaceutical Contract Manufacturing Market Analysis by Scale of Operation
- 7.1 Key Findings
- 7.2 Scale of Operation Segment: Market Attractiveness Index
- 7.3 Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
- 7.4 Clinical
- 7.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- 7.4.2 Market Share by Region, 2025 & 2035 (%)
- 7.5 Commercial
- 7.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- 7.5.2 Market Share by Region, 2025 & 2035 (%)
8 Pharmaceutical Contract Manufacturing Market Analysis by Region
- 8.1 Key Findings
- 8.2 Regional Market Size Estimation and Forecast
9 North America Pharmaceutical Contract Manufacturing Market Analysis
- 9.1 Key Findings
- 9.2 North America Pharmaceutical Contract Manufacturing Market Attractiveness Index
- 9.3 North America Pharmaceutical Contract Manufacturing Market by Country, 2025, 2030 & 2035 (US$ Billion)
- 9.4 North America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Country
- 9.5 North America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Services
- 9.6 North America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Drug Type
- 9.7 North America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by End-users
- 9.8 North America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
- 9.9 U.S. Pharmaceutical Contract Manufacturing Market Analysis
- 9.10 Canada Pharmaceutical Contract Manufacturing Market Analysis
10 Europe Pharmaceutical Contract Manufacturing Market Analysis
- 10.1 Key Findings
- 10.2 Europe Pharmaceutical Contract Manufacturing Market Attractiveness Index
- 10.3 Europe Pharmaceutical Contract Manufacturing Market by Country, 2025, 2030 & 2035 (US$ Billion)
- 10.4 Europe Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Country
- 10.5 Europe Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Services
- 10.6 Europe Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Drug Type
- 10.7 Europe Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by End-users
- 10.8 Europe Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
- 10.9 Germany Pharmaceutical Contract Manufacturing Market Analysis
- 10.10 UK Pharmaceutical Contract Manufacturing Market Analysis
- 10.11 France Pharmaceutical Contract Manufacturing Market Analysis
- 10.12 Italy Pharmaceutical Contract Manufacturing Market Analysis
- 10.13 Spain Pharmaceutical Contract Manufacturing Market Analysis
- 10.14 Russia Pharmaceutical Contract Manufacturing Market Analysis
- 10.15 Switzerland Pharmaceutical Contract Manufacturing Market Analysis
- 10.16 Netherlands Pharmaceutical Contract Manufacturing Market Analysis
- 10.17 Rest of Europe Pharmaceutical Contract Manufacturing Market Analysis
11 Asia Pacific Pharmaceutical Contract Manufacturing Market Analysis
- 11.1 Key Findings
- 11.2 Asia Pacific Pharmaceutical Contract Manufacturing Market Attractiveness Index
- 11.3 Asia Pacific Pharmaceutical Contract Manufacturing Market by Country, 2025, 2030 & 2035 (US$ Billion)
- 11.4 Asia Pacific Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Country
- 11.5 Asia Pacific Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Services
- 11.6 Asia Pacific Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Drug Type
- 11.7 Asia Pacific Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by End-users
- 11.8 Asia Pacific Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
- 11.9 Japan Pharmaceutical Contract Manufacturing Market Analysis
- 11.10 China Pharmaceutical Contract Manufacturing Market Analysis
- 11.11 India Pharmaceutical Contract Manufacturing Market Analysis
- 11.12 Australia Pharmaceutical Contract Manufacturing Market Analysis
- 11.13 South Korea Pharmaceutical Contract Manufacturing Market Analysis
- 11.14 Malaysia Pharmaceutical Contract Manufacturing Market Analysis
- 11.15 Singapore Pharmaceutical Contract Manufacturing Market Analysis
- 11.16 Indonesia Pharmaceutical Contract Manufacturing Market Analysis
- 11.17 Rest of Asia Pacific Pharmaceutical Contract Manufacturing Market Analysis
12 Latin America Pharmaceutical Contract Manufacturing Market Analysis
- 12.1 Key Findings
- 12.2 Latin America Pharmaceutical Contract Manufacturing Market Attractiveness Index
- 12.3 Latin America Pharmaceutical Contract Manufacturing Market by Country, 2025, 2030 & 2035 (US$ Billion)
- 12.4 Latin America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Country
- 12.5 Latin America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Services
- 12.6 Latin America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Drug Type
- 12.7 Latin America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by End-users
- 12.8 Latin America Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
- 12.9 Brazil Pharmaceutical Contract Manufacturing Market Analysis
- 12.10 Mexico Pharmaceutical Contract Manufacturing Market Analysis
- 12.11 Argentina Pharmaceutical Contract Manufacturing Market Analysis
- 12.12 Colombia Pharmaceutical Contract Manufacturing Market Analysis
- 12.13 Rest of Latin America Pharmaceutical Contract Manufacturing Market Analysis
13 MEA Pharmaceutical Contract Manufacturing Market Analysis
- 13.1 Key Findings
- 13.2 MEA Pharmaceutical Contract Manufacturing Market Attractiveness Index
- 13.3 MEA Pharmaceutical Contract Manufacturing Market by Country, 2025, 2030 & 2035 (US$ Billion)
- 13.4 MEA Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Country
- 13.5 MEA Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Services
- 13.6 MEA Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Drug Type
- 13.7 MEA Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by End-users
- 13.8 MEA Pharmaceutical Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
- 13.9 GCC Pharmaceutical Contract Manufacturing Market Analysis
- 13.10 South Africa Pharmaceutical Contract Manufacturing Market Analysis
- 13.11 Rest of MEA Pharmaceutical Contract Manufacturing Market Analysis
14 Company Profiles
- 14.1 Competitive Landscape
- 14.2 Lonza
- 14.2.1 Company Snapshot
- 14.2.2 Company Overview
- 14.2.3 Financial Analysis
- 14.2.3.1 Net Revenue, 2019-2024
- 14.2.3.2 R&D, 2019-2023
- 14.2.3.3 Regional Market Shares, 2024
- 14.2.3.4 Business Segment Market Shares, 2024
- 14.2.4 Service Benchmarking
- 14.2.5 Strategic Outlook
- 14.2.6 SWOT Analysis
- 14.3 Catalent, Inc.
- 14.3.1 Company Snapshot
- 14.3.2 Company Overview
- 14.3.3 Financial Analysis
- 14.3.3.1 Net Revenue, 2019-2024
- 14.3.3.2 Regional Market Shares, 2024
- 14.3.3.3 Business Segment Market Shares, 2024
- 14.3.4 Service Benchmarking
- 14.3.5 Strategic Outlook
- 14.3.6 SWOT Analysis
- 14.4 Recipharm AB
- 14.4.1 Company Snapshot
- 14.4.2 Company Overview
- 14.4.3 Service Benchmarking
- 14.4.4 Strategic Outlook
- 14.4.5 SWOT Analysis
- 14.5 AbbVie Inc.
- 14.5.1 Company Snapshot
- 14.5.2 Company Overview
- 14.5.3 Financial Analysis
- 14.5.3.1 Net Revenue, 2019-2024
- 14.5.3.2 R&D, 2019-2024
- 14.5.3.3 Regional Market Shares, 2024
- 14.5.3.4 Business Segment Market Shares, 2024
- 14.5.4 Service Benchmarking
- 14.5.5 SWOT Analysis
- 14.6 Thermo Fisher Scientific Inc.
- 14.6.1 Company Snapshot
- 14.6.2 Company Overview
- 14.6.3 Financial Analysis
- 14.6.3.1 Net Revenue, 2019-2024
- 14.6.3.2 R&D, 2019-2024
- 14.6.3.3 Regional Market Shares, 2023
- 14.6.3.4 Business Segment Market Shares, 2023
- 14.6.4 Service Benchmarking
- 14.6.5 Strategic Outlook
- 14.6.6 SWOT Analysis
- 14.7 Siegfried Holding AG
- 14.7.1 Company Snapshot
- 14.7.2 Company Overview
- 14.7.3 Financial Analysis
- 14.7.3.1 Net Revenue, 2019-2024
- 14.7.3.2 Regional Market Shares, 2024
- 14.7.3.3 Business Segment Market Shares, 2024
- 14.7.4 Service Benchmarking
- 14.7.5 Strategic Outlook
- 14.8 Evonik Industries AG
- 14.8.1 Company Snapshot
- 14.8.2 Company Overview
- 14.8.3 Financial Analysis
- 14.8.3.1 Net Revenue, 2019-2024
- 14.8.3.2 Regional Market Shares, 2024
- 14.8.3.3 Business Segment Market Shares, 2024
- 14.8.4 Service Benchmarking
- 14.8.5 Strategic Outlook
- 14.9 Boehringer Ingelheim International GmbH
- 14.9.1 Company Snapshot
- 14.9.2 Company Overview
- 14.9.3 Financial Analysis
- 14.9.3.1 Net Revenue, 2019-2023
- 14.9.3.2 Regional Market Shares, 2023
- 14.9.3.3 Business Segment Market Shares, 2023
- 14.9.4 Service Benchmarking
- 14.10 Piramal Pharma Solutions
- 14.10.1 Company Snapshot
- 14.10.2 Company Overview
- 14.10.3 Service Benchmarking
- 14.10.4 Strategic Outlook
- 14.11 Samsung Biologics
- 14.11.1 Company Snapshot
- 14.11.2 Company Overview
- 14.11.3 Financial Analysis
- 14.11.3.1 Net Revenue, 2019-2024
- 14.11.4 Service Benchmarking
- 14.11.5 Strategic Outlook
- 14.12 WuXi AppTec
- 14.12.1 Company Snapshot
- 14.12.2 Company Overview
- 14.12.3 Financial Analysis
- 14.12.3.1 Net Revenue, 2019-2024
- 14.12.3.2 Regional Market Shares, 2024
- 14.12.3.3 Business Segment Market Shares, 2024
- 14.12.4 Service Benchmarking
- 14.12.5 Strategic Outlook
- 14.13 FUJIFILM Diosynth Biotechnologies
- 14.13.1 Company Snapshot
- 14.13.2 Company Overview
- 14.13.3 Financial Analysis
- 14.13.3.1 Net Revenue, 2019-2024
- 14.13.3.2 R&D, 2019-2024
- 14.13.4 Service Benchmarking
- 14.13.5 Strategic Outlook
- 14.14 ICON plc
- 14.14.1 Company Snapshot
- 14.14.2 Company Overview
- 14.14.3 Financial Analysis
- 14.14.3.1 Net Revenue, 2019-2024
- 14.14.3.2 Regional Market Shares, 2024
- 14.14.4 Service Benchmarking
- 14.14.5 Strategic Outlook
- 14.15 Abnova Corporation
- 14.15.1 Company Snapshot
- 14.15.2 Company Overview
- 14.15.3 Service Benchmarking
- 14.15.4 Strategic Outlook
- 14.16 Vetter Pharma
- 14.16.1 Company Snapshot
- 14.16.2 Company Overview
- 14.16.3 Service Benchmarking
- 14.16.4 Strategic Outlook
- 14.17 Aenova Group
- 14.17.1 Company Snapshot
- 14.17.2 Company Overview
- 14.17.3 Financial Analysis
- 14.17.3.1 Net Revenue, 2019-2023
- 14.17.3.2 Regional Market Shares, 2023
- 14.17.3.3 Business Segment Market Shares, 2023
- 14.17.4 Service Benchmarking
- 14.17.5 Strategic Outlook
- 14.18 Almac Group
- 14.18.1 Company Snapshot
- 14.18.2 Company Overview
- 14.18.3 Service Benchmarking
- 14.18.4 Strategic Outlook
- 14.19 Nipro Pharma Corporation
- 14.19.1 Company Snapshot
- 14.19.2 Company Overview
- 14.19.3 Financial Analysis
- 14.19.3.1 Net Revenue, 2019-2024
- 14.19.3.2 R&D, 2019-2024
- 14.19.3.3 Regional Market Shares, 2024
- 14.19.3.4 Business Segment Market Shares, 2024
- 14.19.4 Service Benchmarking
- 14.19.5 Strategic Outlook
- 14.20 Jubilant Pharmova Limited
- 14.20.1 Company Snapshot
- 14.20.2 Company Overview
- 14.20.3 Service Benchmarking
- 14.20.4 Strategic Outlook
- 14.21 Pfizer Inc.
- 14.21.1 Company Snapshot
- 14.21.2 Company Overview
- 14.21.3 Financial Analysis
- 14.21.3.1 Net Revenue, 2019-2024
- 14.21.3.2 R&D, 2019-2024
- 14.21.3.3 Regional Market Shares, 2024
- 14.21.3.4 Business Segment Market Shares, 2024
- 14.21.4 Service Benchmarking
- 14.21.5 Strategic Outlook
- 14.22 Grifols, S.A.
- 14.22.1 Company Snapshot
- 14.22.2 Company Overview
- 14.22.3 Financial Analysis
- 14.22.3.1 Net Revenue, 2019-2024
- 14.22.3.2 R&D, 2019-2024
- 14.22.4 Strategic Outlook
- 14.23 Charles River Laboratories
- 14.23.1 Company Snapshot
- 14.23.2 Company Overview
- 14.23.3 Financial Analysis
- 14.23.3.1 Net Revenue, 2019-2024
- 14.23.3.2 Regional Market Shares, 2023
- 14.23.3.3 Business Segment Market Shares, 2023
- 14.23.4 Service Benchmarking
- 14.23.5 Strategic Outlook
- 14.24 IQVIA Inc.
- 14.24.1 Company Snapshot
- 14.24.2 Company Overview
- 14.24.3 Financial Analysis
- 14.24.3.1 Net Revenue, 2019-2024
- 14.24.3.2 Regional Market Shares, 2024
- 14.24.3.3 Business Segment Market Shares, 2024
- 14.24.4 Service Benchmarking
- 14.24.5 Strategic Outlook
- 14.25 Baxter
- 14.25.1 Company Snapshot
- 14.25.2 Company Overview
- 14.25.3 Financial Analysis
- 14.25.3.1 Net Revenue, 2019-2024
- 14.25.3.2 R&D, 2019-2024
- 14.25.3.3 Regional Market Shares, 2023
- 14.25.3.4 Business Segment Market Shares, 2023
- 14.25.4 Service Benchmarking
- 14.26 Curia Global, Inc.
- 14.26.1 Company Snapshot
- 14.26.2 Company Overview
- 14.26.3 Service Benchmarking
- 14.26.4 Strategic Outlook
- 14.27 Lannett
- 14.27.1 Company Snapshot
- 14.27.2 Company Overview
- 14.27.3 Service Benchmarking
15 Conclusion and Recommendations
- 15.1 Concluding Remarks from Visiongain
- 15.2 Recommendations for Market Players
Product Code: PHA1368
List of Tables
- Table 1 Pharmaceutical Contract Manufacturing Market Snapshot, 2025 & 2035 (US$ Billion, CAGR %)
- Table 2 Patent Expiry
- Table 3 Pharmaceutical Contract Manufacturing Market Forecast by Services, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 4 Pharmaceutical Contract Manufacturing Market Forecast by Pharmaceutical Manufacturing Services, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 5 Pharmaceutical Manufacturing Services Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 6 Pharmaceutical Contract Manufacturing Market Forecast by Drug Development Services, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 7 Drug Development Services Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 8 Pharmaceutical Contract Manufacturing Market Forecast by Biologics Manufacturing Services, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 9 Biologics Manufacturing Services Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 10 Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 11 Branded Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 12 Generics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 13 Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 14 Big Pharmaceutical Companies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 15 Small & Medium-sized Pharmaceutical Companies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 16 Generic Pharmaceutical Companies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 17 Other End-users Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 18 Pharmaceutical Contract Manufacturing Market Forecast by Pharmaceutical Manufacturing Services, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 19 Clinical Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 20 Commercial Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 21 Pharmaceutical Contract Manufacturing Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 22 North America Pharmaceutical Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 23 North America Pharmaceutical Contract Manufacturing Market Forecast by Services, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 24 North America Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 25 North America Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 26 North America Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 27 U.S. Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Bn, AGR %, CAGR %)
- Table 28 Canada Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Bn, AGR %, CAGR %)
- Table 29 Europe Pharmaceutical Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 30 Europe Pharmaceutical Contract Manufacturing Market Forecast by Services, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 31 Europe Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 32 Europe Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 33 Europe Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 34 Germany Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Bn, AGR %, CAGR %)
- Table 35 UK Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Bn, AGR %, CAGR %)
- Table 36 France Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Bn, AGR %, CAGR %)
- Table 37 Italy Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Bn, AGR %, CAGR %)
- Table 38 Spain Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Bn, AGR %, CAGR %)
- Table 39 Russia Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Bn, AGR %, CAGR %)
- Table 40 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Bn, AGR %, CAGR %)
- Table 41 Netherlands Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Bn, AGR %, CAGR %)
- Table 42 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Bn, AGR %, CAGR %)
- Table 43 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 44 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Services, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 45 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 46 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 47 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 48 Japan Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Bn, AGR %, CAGR %)
- Table 49 China Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Bn, AGR %, CAGR %)
- Table 50 India Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Bn, AGR %, CAGR %)
- Table 51 Australia Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Bn, AGR %, CAGR %)
- Table 52 South Korea Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Bn, AGR %, CAGR %)
- Table 53 Malaysia Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Bn, AGR %, CAGR %)
- Table 54 Singapore Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Bn, AGR %, CAGR %)
- Table 55 Indonesia Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Bn, AGR %, CAGR %)
- Table 56 Rest of Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Bn, AGR %, CAGR %)
- Table 57 Latin America Pharmaceutical Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 58 Latin America Pharmaceutical Contract Manufacturing Market Forecast by Services, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 59 Latin America Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 60 Latin America Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 61 Latin America Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 62 Brazil Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Bn, AGR %, CAGR %)
- Table 63 Mexico Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Bn, AGR %, CAGR %)
- Table 64 Argentina Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Bn, AGR %, CAGR %)
- Table 65 Colombia Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Bn, AGR %, CAGR %)
- Table 66 Rest of Latin America Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Bn, AGR %, CAGR %)
- Table 67 MEA Pharmaceutical Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 68 MEA Pharmaceutical Contract Manufacturing Market Forecast by Services, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 69 MEA Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 70 MEA Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 71 MEA Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2025-2035 (US$ Billion, AGR %, CAGR %)
- Table 72 GCC Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Bn, AGR %, CAGR %)
- Table 73 South Africa Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Bn, AGR %, CAGR %)
- Table 74 Rest of MEA Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Bn, AGR %, CAGR %)
- Table 75 Lonza: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 76 Lonza: Service Benchmarking
- Table 77 Lonza: Strategic Outlook
- Table 78 Catalent, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 79 Catalent, Inc.: Service Benchmarking
- Table 80 Catalent, Inc.: Strategic Outlook
- Table 81 Recipharm AB: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 82 Recipharm AB: Service Benchmarking
- Table 83 Recipharm AB: Strategic Outlook
- Table 84 AbbVie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 85 AbbVie Inc.: Service Benchmarking
- Table 86 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 87 Thermo Fisher Scientific Inc.: Service Benchmarking
- Table 88 Thermo Fisher Scientific Inc.: Strategic Outlook
- Table 89 Siegfried Holding AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 90 Siegfried Holding AG: Service Benchmarking
- Table 91 Siegfried Holding AG: Strategic Outlook
- Table 92 Evonik Industries AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 93 Evonik Industries AG: Service Benchmarking
- Table 94 Evonik Industries AG: Strategic Outlook
- Table 95 Boehringer Ingelheim International GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 96 Boehringer Ingelheim International GmbH: Service Benchmarking
- Table 97 Piramal Pharma Solutions: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 98 Piramal Pharma Solutions: Service Benchmarking
- Table 99 Piramal Pharma Solutions: Strategic Outlook
- Table 100 Samsung Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 101 Samsung Biologics: Service Benchmarking
- Table 102 Samsung Biologics: Strategic Outlook
- Table 103 WuXi AppTec: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 104 WuXi AppTec: Service Benchmarking
- Table 105 WuXi AppTec: Strategic Outlook
- Table 106 FUJIFILM Diosynth Biotechnologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 107 FUJIFILM Diosynth Biotechnologies: Service Benchmarking
- Table 108 FUJIFILM Diosynth Biotechnologies: Strategic Outlook
- Table 109 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 110 ICON plc: Service Benchmarking
- Table 111 ICON plc: Strategic Outlook
- Table 112 Abnova Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 113 Abnova Corporation: Service Benchmarking
- Table 114 Abnova Corporation: Strategic Outlook
- Table 115 Vetter Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 116 Vetter Pharma: Service Benchmarking
- Table 117 Vetter Pharma: Strategic Outlook
- Table 118 Aenova Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 119 Aenova Group: Service Benchmarking
- Table 120 Aenova Group: Strategic Outlook
- Table 121 Almac Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 122 Almac Group: Service Benchmarking
- Table 123 Almac Group: Strategic Outlook
- Table 124 Nipro Pharma Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 125 Nipro Pharma Corporation: Service Benchmarking
- Table 126 Nipro Pharma Corporation: Strategic Outlook
- Table 127 Jubilant Pharmova Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 128 Jubilant Pharmova Limited: Service Benchmarking
- Table 129 Jubilant Pharmova Limited: Strategic Outlook
- Table 130 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 131 Pfizer Inc.: Service Benchmarking
- Table 132 Pfizer Inc.: Strategic Outlook
- Table 133 Grifols, S.A.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 134 Grifols, S.A.: Strategic Outlook
- Table 135 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 136 Charles River Laboratories: Service Benchmarking
- Table 137 Charles River Laboratories: Strategic Outlook
- Table 138 IQVIA Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 139 IQVIA Inc.: Service Benchmarking
- Table 140 IQVIA Inc.: Strategic Outlook
- Table 141 Baxter: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 142 Baxter: Service Benchmarking
- Table 143 Curia Global, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 144 Curia Global, Inc.: Service Benchmarking
- Table 145 Curia Global, Inc.: Strategic Outlook
- Table 146 Lannett: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
- Table 147 Lannett: Service Benchmarking
List of Figures
- Figure 1 Pharmaceutical Contract Manufacturing Market Segmentation
- Figure 2 Pharmaceutical Contract Manufacturing Market by Services: Market Attractiveness Index
- Figure 3 Pharmaceutical Contract Manufacturing Market by Drug Type: Market Attractiveness Index
- Figure 4 Pharmaceutical Contract Manufacturing Market by End-users: Market Attractiveness Index
- Figure 5 Pharmaceutical Contract Manufacturing Market by Scale of Operation: Market Attractiveness Index
- Figure 6 Pharmaceutical Contract Manufacturing Market Attractiveness Index by Region
- Figure 7 Pharmaceutical Contract Manufacturing Market: Market Dynamics
- Figure 8 Pharmaceutical Contract Manufacturing Market: Impact Analysis
- Figure 9 R&D Expenditure of Major Companies, 2022 & 2023 (US$ Billion)
- Figure 10 CDER's Novel Drug Approvals by Year
- Figure 11 Pharmaceutical Contract Manufacturing Market: Porter's Five Forces Analysis
- Figure 12 Pharmaceutical Contract Manufacturing Market: PEST Analysis
- Figure 13 Pharmaceutical Contract Manufacturing Market: SWOT Analysis
- Figure 14 Pharmaceutical Contract Manufacturing Market Attractiveness Index by Services
- Figure 15 Pharmaceutical Contract Manufacturing Market Forecast by Services, 2025-2035 (US$ Billion, AGR %)
- Figure 16 Pharmaceutical Contract Manufacturing Market Share Forecast by Services, 2025, 2030, 2035 (%)
- Figure 17 Pharmaceutical Manufacturing Services Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
- Figure 18 Pharmaceutical Manufacturing Services Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- Figure 19 Pharmaceutical Manufacturing Services Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 20 Drug Development Services Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
- Figure 21 Drug Development Services Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- Figure 22 Drug Development Services Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 23 Biologics Manufacturing Services Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
- Figure 24 Biologics Manufacturing Services Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- Figure 25 Biologics Manufacturing Services Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 26 Pharmaceutical Contract Manufacturing Market Attractiveness Index by Services
- Figure 27 Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2025-2035 (US$ Billion, AGR %)
- Figure 28 Pharmaceutical Contract Manufacturing Market Share Forecast by Drug Type, 2025, 2030, 2035 (%)
- Figure 29 Branded Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- Figure 30 Branded Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 31 Generics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- Figure 32 Generics Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 33 Pharmaceutical Contract Manufacturing Market Attractiveness Index by End-users
- Figure 34 Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
- Figure 35 Pharmaceutical Contract Manufacturing Market Share Forecast by End-users, 2025, 2030, 2035 (%)
- Figure 36 Big Pharmaceutical Companies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- Figure 37 Big Pharmaceutical Companies Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 38 Small & Medium-sized Pharmaceutical Companies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- Figure 39 Small & Medium-sized Pharmaceutical Companies Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 40 Generic Pharmaceutical Companies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- Figure 41 Generic Pharmaceutical Companies Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 42 Other End-users Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- Figure 43 Other End-users Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 44 Pharmaceutical Contract Manufacturing Market Attractiveness Index by Scale of Operation
- Figure 45 Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2025-2035 (US$ Billion, AGR %)
- Figure 46 Pharmaceutical Contract Manufacturing Market Share Forecast by Scale of Operation, 2025, 2030, 2035 (%)
- Figure 47 Clinical Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- Figure 48 Clinical Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 49 Commercial Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- Figure 50 Commercial Segment Market Share Forecast by Region, 2025 & 2035 (%)
- Figure 51 Pharmaceutical Contract Manufacturing Market Forecast by Region 2025, 2030, 2035 (Revenue, CAGR%)
- Figure 52 Pharmaceutical Contract Manufacturing Market Share Forecast by Region 2025, 2030, 2035 (%)
- Figure 53 Pharmaceutical Contract Manufacturing Market by Region, 2025-2035 (US$ Bn, AGR %)
- Figure 54 North America Pharmaceutical Contract Manufacturing Market Attractiveness Index
- Figure 55 North America Pharmaceutical Contract Manufacturing Market by Region, 2025, 2030 & 2035 (US$ Billion)
- Figure 56 North America Pharmaceutical Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
- Figure 57 North America Pharmaceutical Contract Manufacturing Market Share Forecast by Country, 2025 & 2035 (%)
- Figure 58 North America Pharmaceutical Contract Manufacturing Market Forecast by Services, 2025-2035 (US$ Billion, AGR %)
- Figure 59 North America Pharmaceutical Contract Manufacturing Market Share Forecast by Services, 2025 & 2035 (%)
- Figure 60 North America Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2025-2035 (US$ Billion, AGR %)
- Figure 61 North America Pharmaceutical Contract Manufacturing Market Share Forecast by Drug Type, 2025 & 2035 (%)
- Figure 62 North America Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
- Figure 63 North America Pharmaceutical Contract Manufacturing Market Share Forecast by End-users, 2025 & 2035 (%)
- Figure 64 North America Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2025-2035 (US$ Billion, AGR %)
- Figure 65 North America Pharmaceutical Contract Manufacturing Market Share Forecast by Scale of Operation, 2025 & 2035 (%)
- Figure 66 U.S. Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Billion, AGR %)
- Figure 67 Canada Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Billion, AGR %)
- Figure 68 Europe Pharmaceutical Contract Manufacturing Market Attractiveness Index
- Figure 69 Europe Pharmaceutical Contract Manufacturing Market by Region, 2025, 2030 & 2035 (US$ Billion)
- Figure 70 Europe Pharmaceutical Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
- Figure 71 Europe Pharmaceutical Contract Manufacturing Market Share Forecast by Country, 2025 & 2035 (%)
- Figure 72 Europe Pharmaceutical Contract Manufacturing Market Forecast by Services, 2025-2035 (US$ Billion, AGR %)
- Figure 73 Europe Pharmaceutical Contract Manufacturing Market Share Forecast by Services, 2025 & 2035 (%)
- Figure 74 Europe Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2025-2035 (US$ Billion, AGR %)
- Figure 75 Europe Pharmaceutical Contract Manufacturing Market Share Forecast by Drug Type, 2025 & 2035 (%)
- Figure 76 Europe Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
- Figure 77 Europe Pharmaceutical Contract Manufacturing Market Share Forecast by End-users, 2025 & 2035 (%)
- Figure 78 Europe Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2025-2035 (US$ Billion, AGR %)
- Figure 79 Europe Pharmaceutical Contract Manufacturing Market Share Forecast by Scale of Operation, 2025 & 2035 (%)
- Figure 80 Germany Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Billion, AGR %)
- Figure 81 UK Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Billion, AGR %)
- Figure 82 France Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Billion, AGR %)
- Figure 83 Italy Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Billion, AGR %)
- Figure 84 Spain Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Billion, AGR %)
- Figure 85 Russia Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Billion, AGR %)
- Figure 86 Switzerland Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Billion, AGR %)
- Figure 87 Netherlands Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Billion, AGR %)
- Figure 88 Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Billion, AGR %)
- Figure 89 Asia Pacific Pharmaceutical Contract Manufacturing Market Attractiveness Index
- Figure 90 Asia Pacific Pharmaceutical Contract Manufacturing Market by Region, 2025, 2030 & 2035 (US$ Billion)
- Figure 91 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
- Figure 92 Asia Pacific Pharmaceutical Contract Manufacturing Market Share Forecast by Country, 2025 & 2035 (%)
- Figure 93 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Services, 2025-2035 (US$ Billion, AGR %)
- Figure 94 Asia Pacific Pharmaceutical Contract Manufacturing Market Share Forecast by Services, 2025 & 2035 (%)
- Figure 95 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2025-2035 (US$ Billion, AGR %)
- Figure 96 Asia Pacific Pharmaceutical Contract Manufacturing Market Share Forecast by Drug Type, 2025 & 2035 (%)
- Figure 97 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
- Figure 98 Asia Pacific Pharmaceutical Contract Manufacturing Market Share Forecast by End-users, 2025 & 2035 (%)
- Figure 99 Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2025-2035 (US$ Billion, AGR %)
- Figure 100 Asia Pacific Pharmaceutical Contract Manufacturing Market Share Forecast by Scale of Operation, 2025 & 2035 (%)
- Figure 101 Japan Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Billion, AGR %)
- Figure 102 China Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Billion, AGR %)
- Figure 103 India Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Billion, AGR %)
- Figure 104 Australia Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Billion, AGR %)
- Figure 105 South Korea Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Billion, AGR %)
- Figure 106 Malaysia Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Billion, AGR %)
- Figure 107 Singapore Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Billion, AGR %)
- Figure 108 Indonesia Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Billion, AGR %)
- Figure 109 Rest of Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Billion, AGR %)
- Figure 110 Latin America Pharmaceutical Contract Manufacturing Market Attractiveness Index
- Figure 111 Latin America Pharmaceutical Contract Manufacturing Market by Region, 2025, 2030 & 2035 (US$ Billion)
- Figure 112 Latin America Pharmaceutical Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
- Figure 113 Latin America Pharmaceutical Contract Manufacturing Market Share Forecast by Country, 2025 & 2035 (%)
- Figure 114 Latin America Pharmaceutical Contract Manufacturing Market Forecast by Services, 2025-2035 (US$ Billion, AGR %)
- Figure 115 Latin America Pharmaceutical Contract Manufacturing Market Share Forecast by Services, 2025 & 2035 (%)
- Figure 116 Latin America Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2025-2035 (US$ Billion, AGR %)
- Figure 117 Latin America Pharmaceutical Contract Manufacturing Market Share Forecast by Drug Type, 2025 & 2035 (%)
- Figure 118 Latin America Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
- Figure 119 Latin America Pharmaceutical Contract Manufacturing Market Share Forecast by End-users, 2025 & 2035 (%)
- Figure 120 Latin America Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2025-2035 (US$ Billion, AGR %)
- Figure 121 Latin America Pharmaceutical Contract Manufacturing Market Share Forecast by Scale of Operation, 2025 & 2035 (%)
- Figure 122 Brazil Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Billion, AGR %)
- Figure 123 Mexico Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Billion, AGR %)
- Figure 124 Argentina Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Billion, AGR %)
- Figure 125 Colombia Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Billion, AGR %)
- Figure 126 Rest of Latin America Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Billion, AGR %)
- Figure 127 MEA Pharmaceutical Contract Manufacturing Market Attractiveness Index
- Figure 128 MEA Pharmaceutical Contract Manufacturing Market by Region, 2025, 2030 & 2035 (US$ Billion)
- Figure 129 MEA Pharmaceutical Contract Manufacturing Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
- Figure 130 MEA Pharmaceutical Contract Manufacturing Market Share Forecast by Country, 2025 & 2035 (%)
- Figure 131 MEA Pharmaceutical Contract Manufacturing Market Forecast by Services, 2025-2035 (US$ Billion, AGR %)
- Figure 132 MEA Pharmaceutical Contract Manufacturing Market Share Forecast by Services, 2025 & 2035 (%)
- Figure 133 MEA Pharmaceutical Contract Manufacturing Market Forecast by Drug Type, 2025-2035 (US$ Billion, AGR %)
- Figure 134 MEA Pharmaceutical Contract Manufacturing Market Share Forecast by Drug Type, 2025 & 2035 (%)
- Figure 135 MEA Pharmaceutical Contract Manufacturing Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
- Figure 136 MEA Pharmaceutical Contract Manufacturing Market Share Forecast by End-users, 2025 & 2035 (%)
- Figure 137 MEA Pharmaceutical Contract Manufacturing Market Forecast by Scale of Operation, 2025-2035 (US$ Billion, AGR %)
- Figure 138 MEA Pharmaceutical Contract Manufacturing Market Share Forecast by Scale of Operation, 2025 & 2035 (%)
- Figure 139 GCC Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Billion, AGR %)
- Figure 140 South Africa Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Billion, AGR %)
- Figure 141 Rest of MEA Pharmaceutical Contract Manufacturing Market Forecast, 2025-2035 (US$ Billion, AGR %)
- Figure 142 Lonza: Net Revenue, 2019-2024 (US$ Million, AGR %)
- Figure 143 Lonza: R&D, 2019-2023 (US$ Million, AGR %)
- Figure 144 Lonza: Regional Market Shares (%), 2024
- Figure 145 Lonza: Business Segment Market Shares (%), 2024
- Figure 146 Lonza: SWOT Analysis
- Figure 147 Catalent, Inc.: Net Revenue, 2019-2024 (US$ Million, AGR %)
- Figure 148 Catalent, Inc.: Regional Market Shares (%), 2024
- Figure 149 Catalent, Inc.: Business Segment Market Shares (%), 2024
- Figure 150 Catalent, Inc.: SWOT Analysis
- Figure 151 Recipharm AB: SWOT Analysis
- Figure 152 AbbVie Inc.: Net Revenue, 2019-2024 (US$ Million, AGR %)
- Figure 153 AbbVie Inc.: R&D, 2019-2024 (US$ Million, AGR %)
- Figure 154 AbbVie Inc.: Regional Market Shares (%), 2024
- Figure 155 AbbVie Inc.: Business Segment Market Shares (%), 2024
- Figure 156 AbbVie Inc.: SWOT Analysis
- Figure 157 Thermo Fisher Scientific Inc.: Net Revenue, 2019-2024 (US$ Million, AGR %)
- Figure 158 Thermo Fisher Scientific Inc.: R&D, 2019-2024 (US$ Million, AGR %)
- Figure 159 Thermo Fisher Scientific Inc.: Regional Market Shares (%), 2023
- Figure 160 Thermo Fisher Scientific Inc.: Business Segment Market Shares (%), 2023
- Figure 161 Thermo Fisher Scientific Inc.: SWOT Analysis
- Figure 162 Siegfried Holding AG: Net Revenue, 2019-2024 (US$ Million, AGR %)
- Figure 163 Siegfried Holding AG: Regional Market Shares (%), 2024
- Figure 164 Siegfried Holding AG: Business Segment Market Shares (%), 2024
- Figure 165 Evonik Industries AG: Net Revenue, 2019-2024 (US$ Million, AGR %)
- Figure 166 Evonik Industries AG: Regional Market Shares (%), 2024
- Figure 167 Evonik Industries AG: Business Segment Market Shares (%), 2024
- Figure 168 Boehringer Ingelheim International GmbH: Net Revenue, 2019-2023 (US$ Million, AGR %)
- Figure 169 Boehringer Ingelheim International GmbH: Regional Market Shares (%), 2023
- Figure 170 Boehringer Ingelheim International GmbH: Business Segment Market Shares (%), 2023
- Figure 171 Samsung Biologics: Net Revenue, 2019-2024 (US$ Million, AGR %)
- Figure 172 WuXi AppTec: Net Revenue, 2019-2024 (US$ Million, AGR %)
- Figure 173 WuXi AppTec: Regional Market Shares (%), 2024
- Figure 174 WuXi AppTec: Business Segment Market Shares (%), 2024
- Figure 175 FUJIFILM Diosynth Biotechnologies: Net Revenue, 2019-2024 (US$ Million, AGR %)
- Figure 176 FUJIFILM Diosynth Biotechnologies: R&D, 2019-2024 (US$ Million, AGR %)
- Figure 177 ICON plc: Net Revenue, 2019-2024 (US$ Million, AGR %)
- Figure 178 ICON plc: Regional Market Shares (%), 2024
- Figure 179 Aenova Group: Net Revenue, 2019-2023 (US$ Million, AGR %)
- Figure 180 Aenova Group: Regional Market Shares (%), 2023
- Figure 181 Aenova Group: Business Segment Market Shares (%), 2023
- Figure 182 Nipro Pharma Corporation: Net Revenue, 2019-2024 (US$ Million, AGR %)
- Figure 183 Nipro Pharma Corporation: R&D, 2019-2024 (US$ Million, AGR %)
- Figure 184 Nipro Pharma Corporation: Regional Market Shares (%), 2024
- Figure 185 Nipro Pharma Corporation: Business Segment Market Shares (%), 2024
- Figure 186 Pfizer Inc.: Net Revenue, 2019-2024 (US$ Million, AGR %)
- Figure 187 Pfizer Inc.: R&D, 2019-2024 (US$ Million, AGR %)
- Figure 188 Pfizer Inc.: Regional Market Shares (%), 2024
- Figure 189 Pfizer Inc.: Business Segment Market Shares (%), 2024
- Figure 190 Grifols, S.A.: Net Revenue, 2019-2024 (US$ Million, AGR %)
- Figure 191 Grifols, S.A.: R&D, 2019-2024 (US$ Million, AGR %)
- Figure 192 Charles River Laboratories: Net Revenue, 2019-2024 (US$ Million, AGR %)
- Figure 193 Charles River Laboratories: Regional Market Shares (%), 2023
- Figure 194 Charles River Laboratories: Business Segment Market Shares (%), 2023
- Figure 195 IQVIA Inc.: Net Revenue, 2019-2024 (US$ Million, AGR %)
- Figure 196 IQVIA Inc.: Regional Market Shares (%), 2024
- Figure 197 IQVIA Inc.: Business Segment Market Shares (%), 2024
- Figure 198 Baxter: Net Revenue, 2019-2024 (US$ Million, AGR %)
- Figure 199 Baxter: R&D, 2019-2024 (US$ Million, AGR %)
- Figure 200 Baxter: Regional Market Shares (%), 2023
- Figure 201 Baxter: Business Segment Market Shares (%), 2023
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.